Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Pharma Industry News ExeGi Pharma’s EXE-346 receives FDA orphan drug designation for pouchitis treatment ExeGi Pharma, a biotechnology company headquartered in Rockville, Maryland, has announced that its live biotherapeutic product (LBP), EXE-346,… bypharmanewsdailyNovember 15, 2020
